RHBC
BNTX icon

R.H. Bluestein & Co’s BioNTech BNTX Stock Holding History

R.H. Bluestein & Co’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,250
Closed -$322K – 389
2021
Q4 		$322K Hold
1,250
– – 0.01% 305
2021
Q3 		$341K Buy
1,250
+250
+25% +$79.5K 0.01% 290
2021
Q2 		$224K Sell
1,000
-1,750
-64% -$330K 0.01% 401
2021
Q1 		$300K Buy
+2,750
New +$292K 0.01% 309

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

R.H. Bluestein & Co's BNTX Position: Q1 2022 in Review

R.H. Bluestein & Co sold out of BioNTech (BNTX) in Q1 2022, closing a stake of 1,250 shares — an estimated $322K sold.

R.H. Bluestein & Co first reported a position in BNTX in Q1 2021 and held it in 4 quarters. The position peaked at $341K in Q3 2021. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2022.

  • R.H. Bluestein & Co reported no remaining BioNTech position as of Q1 2022 after selling out during the quarter.
  • R.H. Bluestein & Co sold 1,250 BioNTech shares in Q1 2022, an estimated $322K.
  • R.H. Bluestein & Co first reported a position in BioNTech in Q1 2021 and held it in 4 quarters.
  • R.H. Bluestein & Co's BioNTech position peaked at $341K in Q3 2021.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2022.

Based on R.H. Bluestein & Co's 13F filing for Q1 2022, filed 11 May 2022.